• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1
1
1
1
1

COUNTRY

1
1

CATEGORIES

  • 4
  • 2
  • 1

PRICE

1
1
3
5

PUBLISHED

0
0
3
5

PRODUCT TYPE

5

Search "Shanghai Fosun Pharmaceutical Group Co., Ltd.-Therapeutic Competitors Report" returned 5 results.

Domestic Chinese Biopharmaceutical Companies

Whether your organization (or department) views domestic Chinese pharmaceutical companies as a competitor, complementor, or as a catalyst, they are becoming an increasing force in the global healthcare...

April 2011
FROM

Type 2 Diabetes - Pipeline Review, H2 2014

Type 2 Diabetes - Pipeline Review, H2 2014 Summary This, ‘Type 2 Diabetes - Pipeline Review, H2 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Competitor Analysis: Insulin

The Competitive Intelligence Report Insulin as of January 2011 provides a competitor analysis in the development pipeline of novel insulin-based products for treatment of type 1 and 2 diabetes Purchase...

January 2011
FROM

Type 2 Diabetes - Pipeline Review, H1 2015

Type 2 Diabetes - Pipeline Review, H1 2015 Summary This, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

February 2015
FROM
Loading Indicator

Our Clients

Carrefour S.A. Dow Chemical Co Ltd. Motorola Solutions, Inc. Pfizer, Inc. Activision Publishing, Inc. 3M Company Estée Lauder Companies Inc.